Daniel M. Aebersold

7.3k total citations · 1 hit paper
225 papers, 4.6k citations indexed

About

Daniel M. Aebersold is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel M. Aebersold has authored 225 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Pulmonary and Respiratory Medicine, 57 papers in Radiation and 52 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel M. Aebersold's work include Advanced Radiotherapy Techniques (56 papers), Head and Neck Cancer Studies (42 papers) and Prostate Cancer Treatment and Research (37 papers). Daniel M. Aebersold is often cited by papers focused on Advanced Radiotherapy Techniques (56 papers), Head and Neck Cancer Studies (42 papers) and Prostate Cancer Treatment and Research (37 papers). Daniel M. Aebersold collaborates with scholars based in Switzerland, Germany and United States. Daniel M. Aebersold's co-authors include Richard Greiner, Karl T. Beer, Jean A. Laissue, Yitzhak Zimmer, Valentin Djonov, Pirus Ghadjar, Michaela Medová, Katja Lindel, Gregg L. Semenza and Alan Dal Pra and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Molecular and Cellular Biology.

In The Last Decade

Daniel M. Aebersold

212 papers receiving 4.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.

2001 522 citations Daniel M. Aebersold et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Daniel M. Aebersold	1.4k	1.4k	1.2k	1.2k	803	225	4.6k
Jason Chia‐Hsien Cheng	859 0.6×	1.4k 1.0×	1.0k 0.8×	715 0.6×	451 0.6×	208	4.5k
Thomas Brunner	1.5k 1.1×	1.9k 1.3×	2.9k 2.3×	908 0.8×	221 0.3×	170	5.9k
Kazuhiko Ogawa	1.2k 0.9×	2.0k 1.5×	1.3k 1.1×	784 0.7×	376 0.5×	320	5.7k
J.H.A.M. Kaanders	602 0.4×	1.2k 0.9×	899 0.7×	868 0.8×	1.0k 1.3×	106	3.6k
Michael Bamberg	1.3k 0.9×	2.3k 1.7×	1.0k 0.8×	722 0.6×	419 0.5×	179	6.9k
Roger Ove	978 0.7×	1.7k 1.3×	2.0k 1.6×	422 0.4×	1.7k 2.2×	36	4.1k
James M. Larner	1.1k 0.8×	1.8k 1.3×	943 0.8×	436 0.4×	193 0.2×	151	4.3k
Bin S. Teh	1.2k 0.9×	4.0k 2.9×	2.0k 1.6×	1.1k 0.9×	715 0.9×	374	8.4k
Stephan Bodis	1.6k 1.1×	1.4k 1.0×	1.7k 1.3×	676 0.6×	148 0.2×	106	5.3k
Masato Hareyama	836 0.6×	3.3k 2.4×	1.6k 1.3×	344 0.3×	1.1k 1.4×	178	6.2k

Countries citing papers authored by Daniel M. Aebersold

Since Specialization

Citations

This map shows the geographic impact of Daniel M. Aebersold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Aebersold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Aebersold more than expected).

Fields of papers citing papers by Daniel M. Aebersold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel M. Aebersold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Aebersold. The network helps show where Daniel M. Aebersold may publish in the future.

Co-authorship network of co-authors of Daniel M. Aebersold

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel M. Aebersold. A scholar is included among the top collaborators of Daniel M. Aebersold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel M. Aebersold. Daniel M. Aebersold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berger, Martin D., Yves Borbély, Ekin Ermiş, et al.. (2024). Cone Beam Computed Tomography-Based Online Adaptive Radiation Therapy of Esophageal Cancer: First Clinical Experience and Dosimetric Benefits. Advances in Radiation Oncology. 10(1). 101656–101656. 3 indexed citations

Mohamad, Osama, et al.. (2024). Focal brachytherapy as definitive treatment for localized prostate cancer: A systematic review and meta-analysis. Brachytherapy. 23(3). 309–320. 4 indexed citations

Gückenberger, Matthias, Charlotte Billiet, Daniel Schnell, et al.. (2024). Dose‐intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial. Cancer. 130(15). 2713–2722. 14 indexed citations

Willmann, Jonas, Nicolaus Andratschke, Ekin Ermiş, et al.. (2023). Deep-Learning-Based Dose Predictor for Glioblastoma–Assessing the Sensitivity and Robustness for Dose Awareness in Contouring. Cancers. 15(17). 4226–4226. 5 indexed citations

Schröder, Christina, Robert Förster, Daniel M. Aebersold, et al.. (2023). Applications of Machine Learning in Palliative Care: A Systematic Review. Cancers. 15(5). 1596–1596. 26 indexed citations

Mélin, Nicolas, Daniel Sánchez‐Taltavull, Tess M. Brodie, et al.. (2022). A new mouse model of radiation-induced liver disease reveals mitochondrial dysfunction as an underlying fibrotic stimulus. JHEP Reports. 4(7). 100508–100508. 18 indexed citations

Schanne, Daniel H., Olgun Eliçin, Roland Giger, et al.. (2022). Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy—A Systematic Review. Biomedicines. 10(12). 3288–3288. 5 indexed citations

Schanne, Daniel H., et al.. (2022). Stereotactic body radiotherapy for recurrent hemoptysis due to chronic pulmonary aspergillosis: a case report and systematic review of the literature. Strahlentherapie und Onkologie. 199(2). 192–200. 4 indexed citations

Shelan, Mohamed, Daniel M. Aebersold, Dirk Böhmer, et al.. (2021). Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries. Strahlentherapie und Onkologie. 197(11). 993–1000. 4 indexed citations

10.

Mélin, Nicolas, Daniel Sánchez‐Taltavull, René Fahrner, et al.. (2021). Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury. Cell Death and Disease. 12(4). 366–366. 13 indexed citations

11.

Aebersold, Daniel M., et al.. (2020). MET targeting: time for a rematch. Oncogene. 39(14). 2845–2862. 48 indexed citations

12.

Frei, Daniel, W. Volken, Marco Stampanoni, et al.. (2019). Adaptive step size algorithm to increase efficiency of proton macro Monte Carlo dose calculation. Radiation Oncology. 14(1). 165–165. 5 indexed citations

13.

Nisa, Lluís, Paola Francica, Roland Giger, et al.. (2019). Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 19(2). 614–626. 11 indexed citations

14.

Nisa, Lluís, David Barras, Michaela Medová, et al.. (2018). Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent Disease. Molecular Cancer Research. 16(12). 1912–1926. 23 indexed citations

15.

Aebersold, Daniel M., et al.. (2018). The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer. Molecular Cancer. 17(1). 27–27. 39 indexed citations

16.

Eliçin, Olgun, Martina A. Broglie, Niklaus Fankhauser, et al.. (2018). Comparison of contemporary staging systems for oropharynx cancer in a surgically treated multi‐institutional cohort. Head & Neck. 41(5). 1395–1402. 3 indexed citations

17.

Francica, Paola, Lluís Nisa, Daniel M. Aebersold, et al.. (2016). Depletion of FOXM1 via MET Targeting Underlies Establishment of a DNA Damage–Induced Senescence Program in Gastric Cancer. Clinical Cancer Research. 22(21). 5322–5336. 27 indexed citations

18.

Medová, Michaela, Lluís Nisa, Paola Francica, et al.. (2015). Impact of p53 Status on Radiosensitization of Tumor Cells by MET Inhibition–Associated Checkpoint Abrogation. Molecular Cancer Research. 13(12). 1544–1553. 8 indexed citations

19.

Medová, Michaela, Bruno Streit, Paola Francica, et al.. (2013). The Novel ATP-Competitive Inhibitor of the MET Hepatocyte Growth Factor Receptor EMD1214063 Displays Inhibitory Activity against Selected MET-Mutated Variants. Molecular Cancer Therapeutics. 12(11). 2415–2424. 25 indexed citations

20.

Aebersold, Daniel M., Yoav D. Shaul, Yuval Yung, et al.. (2004). Extracellular Signal-Regulated Kinase 1c (ERK1c), a Novel 42-Kilodalton ERK, Demonstrates Unique Modes of Regulation, Localization, and Function. Molecular and Cellular Biology. 24(22). 10000–10015. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact